MRPs can export a wide range of chemotherapeutic agents out of cancer cells, thereby reducing the intracellular concentrations of these drugs and making them less effective. This efflux mechanism leads to the development of resistance against multiple drugs, complicating the treatment protocols for cancer patients.
